Human Rights and Case

3852 Words16 Pages
1. Title of the Case: ABBOTT LABORATORIES: DRUG PRICING CHUTZPAH 2. Statement of the Problem: * Is the increase of the anti-AIDS drug Norvir by Abbott justifiable? 3. Statement of Relevant Facts from the Case i. The company (Abbott) raised its anti-AIDS drug Norvir by 400 percent unless the product is used in conjunction with other Abbott products where there will be no price increase. ii. Norvir is generally too toxic for safe use as a protease inhibitor however works well as a booster to increase the efficacy of other protease inhibitors however the price increase of Norivr does not apply when the product is used as a booster with another of Abbot’s protease inhibitor product Kaletra. iii. Price…show more content…
vii. Together with the increase in price, the company also showed an action that gives unhealthy competition in which it wants that its products would be cheaper than the others. viii. Novir is priced more expensive compared to other countries whose income is higher than United States. ix. The negative impact of the increase is amplified to those who have low income. 8. Significant Ethical and Moral Issues and Implication of the case (5) x. Government –funded inventions should be priced at a reasonable term as Bayh-Dole Act stated in which case is not followed. xi. A health products which price is increased at 400% is outrageous especially it is a life-or-death AIDS drug. xii. This move of increasing the price makes the customers in a tight spot especially those who are in a life-or-death situation. xiii. The drug was invented on a grant from the U.S. federal government which means that the money on inventing the drug came from the people. This is a double payment of the citizens of U.S. xiv. The company doesn’t think of the situation of its customers and only decides where the company has the upper hand. 1. Title of the Case: AIG: DEFERRED PROSECUTIONS ON THE RISE 2. Statement of the Problem * Are deferred prosecution part of the problem or part of the solution? 3. Statement of Relevant
Open Document